Doctors use medicines to help lower these blood fats and to keep plaques stable, but these drugs do not remove the plaques.

Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the global population, with rates exceeding 40% in ...

The Global Cardiovascular Disease Market, valued at approximately USD 171.55 million in 2023, is projected to expand at a steady compound annual growth rate (CAGR) of 5% during the forecast period ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...